Dr Marc Rogers speaks to DDW about the current trends and challenges in ion channel drug discovery and clinical development. Axxam invited Dr Rogers to present a KOL webinar on the topic of ‘ion channel drug discovery’ based on his academic and industry experience in the… Read More
Metrion Biosciences, a specialist ion channel contract research and drug discovery company, and The KCNC1 Foundation, a not-for-profit organisation focused on the development of a treatment for an ultra-rare genetic disorder, have entered a collaboration to progress a hit identification research project for small molecule modulators of the potassium… Read More
Metrion Biosciences, the specialist ion channel CRO and drug discovery company and Sosei Group, an international biopharmaceutical group, will apply Sosei Heptares’ structure-based drug design (SBDD) expertise and platform to ion channels for the first time through a new strategic collaboration. Ion channels are a class of integral membrane proteins… Read More
